{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32905276", "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.0c02165"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "5", "Issue": "34", "PubDate": {"Year": "2020", "Month": "Sep", "Day": "01"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.", "Pagination": {"StartPage": "21550", "EndPage": "21560", "MedlinePgn": "21550-21560"}, "Abstract": {"AbstractText": ["The sphingosine kinase-1/sphingosine-1-phosphate pathway is linked with the cancer progression and survival of the chemotherapy-challenged cells. Sphingosine kinase-1 (SphK1) has emerged as an attractive drug target, but their inhibitors from natural sources are limited. In this study, we have chosen harmaline, one of the \u03b2-carboline alkaloids, and report its mechanism of binding to SphK1 and subsequent inhibition. Molecular docking combined with fluorescence binding studies revealed that harmaline binds to the substrate-binding pocket of SphK1 with an appreciable binding affinity and significantly inhibits the kinase activity of SphK1 with an IC<sub>50</sub> value in the micromolar range. The cytotoxic effect of harmaline on non-small-cell lung cancer cells by MTT assay was found to be higher for H1299 compared to A549. Harmaline induces apoptosis in non-small-cell lung carcinoma cells (H1299 and A549), possibly via the intrinsic pathway. Our findings suggest that harmaline could be implicated as a scaffold for designing potent anticancer molecules with SphK1 inhibitory potential."], "CopyrightInformation": "Copyright \u00a9 2020 American Chemical Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Roy", "ForeName": "Sonam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Mohammad", "ForeName": "Taj", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Gupta", "ForeName": "Preeti", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Dahiya", "ForeName": "Rashmi", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, Uttar Pradesh, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India."}], "LastName": "Parveen", "ForeName": "Shahnaz", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, Uttar Pradesh, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Medicine, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Kingdom of Saudi Arabia."}], "LastName": "Hasan", "ForeName": "Gulam Mustafa", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Torre L. A.; Siegel R. L.; Jemal A.. Lung cancer statistics. In Lung cancer and personalized medicine; Springer: 2016; 1\u201319.", "ArticleIdList": ["26667336"]}, {"Citation": "Jemal A.; Siegel R.; Ward E.; Murray T.; Xu J.; Thun M. J. Cancer statistics, 2007. Ca-Cancer J. Clin. 2007, 57, 43\u201366. 10.3322/canjclin.57.1.43.", "ArticleIdList": ["10.3322/canjclin.57.1.43", "17237035"]}, {"Citation": "Alberg A. J.; Samet J. M. Epidemiology of lung cancer. Chest 2003, 123, 21S\u201349S. 10.1378/chest.123.1_suppl.21S.", "ArticleIdList": ["10.1378/chest.123.1_suppl.21S", "12527563"]}, {"Citation": "Travis W. D.; Travis L. B.; Devesa S. S. Lung cancer. Cancer 1995, 75, 191\u2013202. 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y.", "ArticleIdList": ["10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y", "8000996"]}, {"Citation": "Jacques J.; Hill D.; Shier K.; Jindani A.; Miller A. Appraisal of the World Health Organization classification of lung tumours. Can. Med. Assoc. J. 1980, 122, 897.", "ArticleIdList": ["PMC1801636", "7370873"]}, {"Citation": "Temel J. S.; Greer J. A.; Muzikansky A.; et al. Early palliative care for patients with metastatic non\u2013small-cell lung cancer. N. Engl. J. Med. 2010, 363, 733\u2013742. 10.1056/NEJMoa1000678.", "ArticleIdList": ["10.1056/NEJMoa1000678", "20818875"]}, {"Citation": "Breindel J. L.; Haskins J. W.; Cowell E. P.; Zhao M.; Nguyen D. X.; Stern D. F. EGF Receptor Activates MET through MAPK to Enhance Non\u2013Small Cell Lung Carcinoma Invasion and Brain Metastasis. Cancer Res. 2013, 73, 5053\u20135065. 10.1158/0008-5472.CAN-12-3775.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-3775", "PMC3745527", "23794705"]}, {"Citation": "Yang P.; Allen M. S.; Aubry M. C.; et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005, 128, 452\u2013462. 10.1378/chest.128.1.452.", "ArticleIdList": ["10.1378/chest.128.1.452", "16002972"]}, {"Citation": "Boolell V.; Alamgeer M.; Watkins D. N.; Ganju V. The evolution of therapies in non-small cell lung cancer. Cancers 2015, 7, 1815\u20131846. 10.3390/cancers7030864.", "ArticleIdList": ["10.3390/cancers7030864", "PMC4586797", "26371045"]}, {"Citation": "Raparia K.; Villa C.; DeCamp M. M.; Patel J. D.; Mehta M. P. Molecular profiling in non\u2013small cell lung cancer: a step toward personalized medicine. Arch. Pathol. Lab. Med. 2013, 137, 481\u2013491. 10.5858/arpa.2012-0287-RA.", "ArticleIdList": ["10.5858/arpa.2012-0287-RA", "23544937"]}, {"Citation": "Spiegel S.; Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 2002, 277, 25851\u201325854. 10.1074/jbc.R200007200.", "ArticleIdList": ["10.1074/jbc.R200007200", "12011102"]}, {"Citation": "Wang Z.; Min X.; Xiao S.-H.; et al. Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. Structure 2013, 21, 798\u2013809. 10.1016/j.str.2013.02.025.", "ArticleIdList": ["10.1016/j.str.2013.02.025", "23602659"]}, {"Citation": "Hatoum D.; Haddadi N.; Lin Y.; Nassif N. T.; McGowan E. M. Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget. Oncotarget 2017, 8, 36898.10.18632/oncotarget.16370.", "ArticleIdList": ["10.18632/oncotarget.16370", "PMC5482707", "28415564"]}, {"Citation": "Mizugishi K.; Yamashita T.; Olivera A.; Miller G. F.; Spiegel S.; Proia R. L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 2005, 25, 11113\u201311121. 10.1128/MCB.25.24.11113-11121.2005.", "ArticleIdList": ["10.1128/MCB.25.24.11113-11121.2005", "PMC1316977", "16314531"]}, {"Citation": "Allende M. L.; Sasaki T.; Kawai H.; et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 2004, 279, 52487\u201352492. 10.1074/jbc.M406512200.", "ArticleIdList": ["10.1074/jbc.M406512200", "15459201"]}, {"Citation": "Wattenberg B. W.; Pitson S. M.; Raben D. M. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J. Lipid Res. 2006, 47, 1128\u20131139. 10.1194/jlr.R600003-JLR200.", "ArticleIdList": ["10.1194/jlr.R600003-JLR200", "16520486"]}, {"Citation": "Pitson S. M.; Moretti P. A.; Zebol J. R.; et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003, 22, 5491\u20135500. 10.1093/emboj/cdg540.", "ArticleIdList": ["10.1093/emboj/cdg540", "PMC213794", "14532121"]}, {"Citation": "Pitson S. M.; Xia P.; Leclercq T. M.; et al. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J. Exp. Med. 2005, 201, 49\u201354. 10.1084/jem.20040559.", "ArticleIdList": ["10.1084/jem.20040559", "PMC2212769", "15623571"]}, {"Citation": "Pyne N. J.; Pyne S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 2010, 10, 489\u2013503. 10.1038/nrc2875.", "ArticleIdList": ["10.1038/nrc2875", "20555359"]}, {"Citation": "Spiegel S.; Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4, 397\u2013407. 10.1038/nrm1103.", "ArticleIdList": ["10.1038/nrm1103", "12728273"]}, {"Citation": "Newton J.; Lima S.; Maceyka M.; Spiegel S. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. Exp. Cell Res. 2015, 333, 195.10.1016/j.yexcr.2015.02.025.", "ArticleIdList": ["10.1016/j.yexcr.2015.02.025", "PMC4415605", "25770011"]}, {"Citation": "Huang Y.-L.; Huang W.-P.; Lee H. Roles of sphingosine 1-phosphate on tumorigenesis. World J. Biol. Chem 2011, 2, 25.10.4331/wjbc.v2.i2.25.", "ArticleIdList": ["10.4331/wjbc.v2.i2.25", "PMC3083992", "21537487"]}, {"Citation": "Guillermet-Guibert J.; Davenne L.; Pchejetski D.; et al. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Mol. Cancer Ther. 2009, 8, 809\u2013820. 10.1158/1535-7163.MCT-08-1096.", "ArticleIdList": ["10.1158/1535-7163.MCT-08-1096", "19372554"]}, {"Citation": "Zheng X.; Li W.; Ren L.; et al. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy. Pharmacol. Ther. 2019, 195, 85\u201399. 10.1016/j.pharmthera.2018.10.011.", "ArticleIdList": ["10.1016/j.pharmthera.2018.10.011", "30347210"]}, {"Citation": "Liu L.; Zhou X.; Zhang J.; et al. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Eur. Rev. Med. Pharmacol. Sci 2018, 22, 8722\u20138730. 10.26355/eurrev_201812_16637.", "ArticleIdList": ["10.26355/eurrev_201812_16637", "30575912"]}, {"Citation": "Liu S.-Q.; Huang J.-A.; Qin M.-B.; et al. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. Int. J. Colorectal Dis. 2012, 27, 1569\u20131578. 10.1007/s00384-012-1510-y.", "ArticleIdList": ["10.1007/s00384-012-1510-y", "22684547"]}, {"Citation": "Zhu Y. J.; You H.; Tan J. X.; et al. Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer. Oncol. Lett. 2017, 14, 63\u201372. 10.3892/ol.2017.6134.", "ArticleIdList": ["10.3892/ol.2017.6134", "PMC5494825", "28693136"]}, {"Citation": "Nava V. E.; Hobson J. P.; Murthy S.; Milstien S.; Spiegel S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp. Cell Res. 2002, 281, 115\u2013127. 10.1006/excr.2002.5658.", "ArticleIdList": ["10.1006/excr.2002.5658", "12441135"]}, {"Citation": "Dayon A.; Brizuela L.; Martin C.; et al. Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival. PLoS One 2009, 4, e804810.1371/journal.pone.0008048.", "ArticleIdList": ["10.1371/journal.pone.0008048", "PMC2779655", "19956567"]}, {"Citation": "Datta A.; Loo S. Y.; Huang B.; et al. SPHK1 regulates proliferation and survival responses in triple-negative breast cancer. Oncotarget 2014, 5, 5920.10.18632/oncotarget.1874.", "ArticleIdList": ["10.18632/oncotarget.1874", "PMC4171602", "25153718"]}, {"Citation": "Bonhoure E.; Pchejetski D.; Aouali N.; et al. Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1. Leukemia 2006, 20, 95\u2013102. 10.1038/sj.leu.2404023.", "ArticleIdList": ["10.1038/sj.leu.2404023", "16281067"]}, {"Citation": "Akao Y.; Banno Y.; Nakagawa Y.; et al. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem. Biophys. Res. Commun. 2006, 342, 1284\u20131290. 10.1016/j.bbrc.2006.02.070.", "ArticleIdList": ["10.1016/j.bbrc.2006.02.070", "16516161"]}, {"Citation": "Ni M.; Shi X.-L.; Qu Z.-G.; Jiang H.; Chen Z.-Q.; Hu J. Epithelial mesenchymal transition of non\u2013small\u2013cell lung cancer cells A549 induced by SPHK1. Asian Pac. J. Trop. Med. 2015, 8, 142\u2013146. 10.1016/S1995-7645(14)60305-9.", "ArticleIdList": ["10.1016/S1995-7645(14)60305-9", "25902029"]}, {"Citation": "Song L.; Xiong H.; Li J.; et al. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-\u03baB pathway in human non\u2013small cell lung cancer. Clin. Cancer Res. 2011, 17, 1839\u20131849. 10.1158/1078-0432.CCR-10-0720.", "ArticleIdList": ["10.1158/1078-0432.CCR-10-0720", "21325072"]}, {"Citation": "Zhu L.; Wang Z.; Lin Y.; et al. Sphingosine kinase 1 enhances the invasion and migration of non-small cell lung cancer cells via the AKT pathway. Oncol. Rep. 2015, 33, 1257\u20131263. 10.3892/or.2014.3683.", "ArticleIdList": ["10.3892/or.2014.3683", "25529771"]}, {"Citation": "Igarashi Y.; Hakomori S.; Toyokuni T.; et al. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 1989, 28, 6796\u20136800. 10.1021/bi00443a002.", "ArticleIdList": ["10.1021/bi00443a002", "2479412"]}, {"Citation": "Cohen J. A.; Barkhof F.; Comi G.; et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 2010, 362, 402\u2013415. 10.1056/NEJMoa0907839.", "ArticleIdList": ["10.1056/NEJMoa0907839", "20089954"]}, {"Citation": "Permpongkosol S.; Wang J. D.; Takahara S.; et al. Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: Modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis. Int. J. Cancer 2002, 98, 167\u2013172. 10.1002/ijc.10178.", "ArticleIdList": ["10.1002/ijc.10178", "11857403"]}, {"Citation": "Wang J.; Knapp S.; Pyne N. J.; Pyne S.; Elkins J. M. Crystal structure of sphingosine kinase 1 with PF-543. ACS Med. Chem. Lett. 2014, 5, 1329\u20131333. 10.1021/ml5004074.", "ArticleIdList": ["10.1021/ml5004074", "PMC4265818", "25516793"]}, {"Citation": "Gandy K. A. O.; Obeid L. M. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2013, 1831, 157\u2013166. 10.1016/j.bbalip.2012.07.002.", "ArticleIdList": ["10.1016/j.bbalip.2012.07.002", "PMC3661866", "22801037"]}, {"Citation": "Gupta P.; Mohammad T.; Dahiya R.; et al. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy. Sci. Rep. 2019, 9, 1\u201315. 10.1038/s41598-019-55199-3.", "ArticleIdList": ["10.1038/s41598-019-55199-3", "PMC6904568", "31822735"]}, {"Citation": "Jairajpuri D. S.; Mohammad T.; Adhikari K.; Gupta P.; et al. Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy. ACS Omega 2020, 5, 14720.10.1021/acsomega.0c01511.", "ArticleIdList": ["10.1021/acsomega.0c01511", "PMC7315586", "32596609"]}, {"Citation": "Khan P.; Queen A.; Mohammad T.; et al. Identification of alpha-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4. J. Nat. Prod. 2019, 82, 2252\u20132261. 10.1021/acs.jnatprod.9b00372.", "ArticleIdList": ["10.1021/acs.jnatprod.9b00372", "31343173"]}, {"Citation": "Khan P.; Rahman S.; Queen A.; et al. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies. Sci. Rep. 2017, 7, 9470.10.1038/s41598-017-09941-4.", "ArticleIdList": ["10.1038/s41598-017-09941-4", "PMC5573368", "28842631"]}, {"Citation": "Naz F.; Shahbaaz M.; Bisetty K.; Islam A.; Ahmad F.; Hassan M. I. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition. OMICS 2015, 19, 700\u2013711. 10.1089/omi.2015.0111.", "ArticleIdList": ["10.1089/omi.2015.0111", "26565604"]}, {"Citation": "Yousuf M.; Shamsi A.; Khan P.; Shahbaaz M.; AlAjmi M. F.; Hussain A.; Hassan G. M.; Islam A.; Haque Q. M. R.; Hassan I. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6. Int. J. Mol. Sci. 2020, 21, 3526.10.3390/ijms21103526.", "ArticleIdList": ["10.3390/ijms21103526", "PMC7278979", "32429317"]}, {"Citation": "Mukherjee A. K.; Basu S.; Sarkar N.; Ghosh A. C. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 2001, 8, 1467\u20131486. 10.2174/0929867013372094.", "ArticleIdList": ["10.2174/0929867013372094", "11562277"]}, {"Citation": "Plano D.; Amin S.; Sharma A. K. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors: Miniperspective. J. Med. Chem. 2014, 57, 5509\u20135524. 10.1021/jm4011687.", "ArticleIdList": ["10.1021/jm4011687", "24471412"]}, {"Citation": "Funaki M.; Kitabayashi J.; Shimakami T.; et al. Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo. Sci. Rep. 2017, 7, 1\u201313. 10.1038/s41598-017-17285-2.", "ArticleIdList": ["10.1038/s41598-017-17285-2", "PMC5717167", "29208982"]}, {"Citation": "Yang H.; Li Y.; Chai H.; Yakura T.; Liu B.; Yao Q. Synthesis and biological evaluation of 2-epi-jaspine B analogs as selective sphingosine kinase 1 inhibitors. Bioorg. Chem. 2019, 103369.10.1016/j.bioorg.2019.103369.", "ArticleIdList": ["10.1016/j.bioorg.2019.103369", "31703810"]}, {"Citation": "Lu P.-H.; Chen M.-B.; Liu Y.-Y.; et al. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells. Oncotarget 2017, 8, 22800.10.18632/oncotarget.15205.", "ArticleIdList": ["10.18632/oncotarget.15205", "PMC5410263", "28206952"]}, {"Citation": "Gao M.-Q.; Gao H.; Han M.; Liu K.-L.; Peng J.-J.; Han Y.-T. Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat. Am. J. Cancer Res. 2017, 7, 1501.", "ArticleIdList": ["PMC5523031", "28744400"]}, {"Citation": "Mahmoudian M.; Jalipour H.; Salehian Dardashti P. Toxicity of Peganum harmala: review and a case report. Iran. J. Pharmacol. Ther. 2002, 1, 1."}, {"Citation": "Cao R.; Peng W.; Wang Z.; Xu A. \u03b2-Carboline alkaloids: biochemical and pharmacological functions. Curr. Med. Chem. 2007, 14, 479\u2013500. 10.2174/092986707779940998.", "ArticleIdList": ["10.2174/092986707779940998", "17305548"]}, {"Citation": "Li Y.; Liang F.; Jiang W.; et al. DH334, a \u03b2-carboline anti-cancer drug, inhibits the CDK activity of budding yeast. Cancer Biol. Ther. 2007, 6, 1204\u20131210. 10.4161/cbt.6.8.4382.", "ArticleIdList": ["10.4161/cbt.6.8.4382", "17622795"]}, {"Citation": "Khan F. A.; Maalik A.; Iqbal Z.; Malik I. Recent pharmacological developments in \u03b2-carboline alkaloid \u201charmaline\u201d. Eur. J. Pharmacol. 2013, 721, 391\u2013394. 10.1016/j.ejphar.2013.05.003.", "ArticleIdList": ["10.1016/j.ejphar.2013.05.003", "23707188"]}, {"Citation": "Moloudizargari M.; Mikaili P.; Aghajanshakeri S.; Asghari M. H.; Shayegh J. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn. Rev. 2013, 7, 199.10.4103/0973-7847.120524.", "ArticleIdList": ["10.4103/0973-7847.120524", "PMC3841998", "24347928"]}, {"Citation": "Cumming P.; Vincent S. R. Inhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1, 2, 3, 4-tetrahydroacridine (tacrine) and by \u03b2-carbolines. Biochem. Pharmacol. 1992, 44, 989\u2013992. 10.1016/0006-2952(92)90133-4.", "ArticleIdList": ["10.1016/0006-2952(92)90133-4", "1530666"]}, {"Citation": "Suleiman M.; Reeves J. Inhibition of Na+-Ca2+ exchange mechanism in cardiac sarcolemmal vesicles by harmaline. Comp. Biochem. Physiol., Part C: C, Comp. Pharmacol. Toxicol. 1987, 88, 197.10.1016/0742-8413(87)90068-5.", "ArticleIdList": ["10.1016/0742-8413(87)90068-5", "2890483"]}, {"Citation": "Herraiz T.; Gonz\u00e1lez D.; Anc\u00edn-Azpilicueta C.; Ar\u00e1n V.; Guill\u00e9n H. \u03b2-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem. Toxicol. 2010, 48, 839\u2013845. 10.1016/j.fct.2009.12.019.", "ArticleIdList": ["10.1016/j.fct.2009.12.019", "20036304"]}, {"Citation": "El Gendy M. A.; El-Kadi A. O. Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. Drug Metab. Lett. 2009, 3, 212\u2013216. 10.2174/187231209790218163.", "ArticleIdList": ["10.2174/187231209790218163", "20041830"]}, {"Citation": "El Gendy M. A.; El-Kadi A. O. Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice. BioMed Res. Int. 2013, 2013, 1.10.1155/2013/258095.", "ArticleIdList": ["10.1155/2013/258095", "PMC3591235", "23509697"]}, {"Citation": "Wang Y.; Wang C.; Jiang C.; Zeng H.; He X. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci. Rep. 2015, 5, 1\u201310. 10.1038/srep18613.", "ArticleIdList": ["10.1038/srep18613", "PMC4683523", "26678950"]}, {"Citation": "Xu B.; Li M.; Yu Y.; et al. Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. Oncol. Lett. 2018, 15, 1931\u20131936. 10.3892/ol.2017.7495.", "ArticleIdList": ["10.3892/ol.2017.7495", "PMC5774346", "29434892"]}, {"Citation": "Gupta P.; Khan F. I.; Roy S.; et al. Functional implications of pH-induced conformational changes in the Sphingosine kinase 1. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2020, 225, 117453.10.1016/j.saa.2019.117453.", "ArticleIdList": ["10.1016/j.saa.2019.117453", "31446356"]}, {"Citation": "Mocz G., Ross J.A.. Fluorescence techniques in analysis of protein\u2013ligand interactions. Protein-Ligand Interactions; Springer, 2013:169\u2013210.", "ArticleIdList": ["23729253"]}, {"Citation": "Ojha B.; Das G. Role of hydrophobic and polar interactions for BSA\u2013amphiphile composites. Chem. Phys. Lipids 2011, 164, 144\u2013150. 10.1016/j.chemphyslip.2010.12.004.", "ArticleIdList": ["10.1016/j.chemphyslip.2010.12.004", "21185815"]}, {"Citation": "Guo M.; Zou J.-W.; Yi P.-G.; Shang Z.-C.; Hu G.-X.; Yu Q.-S. Binding interaction of gatifloxacin with bovine serum albumin. Anal. Sci. 2004, 20, 465\u2013470. 10.2116/analsci.20.465.", "ArticleIdList": ["10.2116/analsci.20.465", "15068289"]}, {"Citation": "Freire E.; Mayorga O. L.; Straume M. Isothermal titration calorimetry. Anal. Chem. 1990, 62, 950A\u2013959A. 10.1021/ac00217a002.", "ArticleIdList": ["10.1021/ac00217a002"]}, {"Citation": "Buurman E. T.; Andrews B.; Gao N.; et al. In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae. J. Biol. Chem. 2011, 286, 40734\u201340742. 10.1074/jbc.M111.274068.", "ArticleIdList": ["10.1074/jbc.M111.274068", "PMC3220512", "21984832"]}, {"Citation": "Lyles R. H.; Poindexter C.; Evans A.; Brown M.; Cooper C. R. Nonlinear model-based estimates of IC50 for studies involving continuous therapeutic dose\u2013response data. Contemp. Clin. Trials 2008, 29, 878\u2013886. 10.1016/j.cct.2008.05.009.", "ArticleIdList": ["10.1016/j.cct.2008.05.009", "PMC2586183", "18582601"]}, {"Citation": "Jiang C.; Yang Y.; Yang Y.; et al. Long noncoding RNA (lncRNA) HOTAIR affects tumorigenesis and metastasis of non-small cell lung cancer by upregulating miR-613. Oncol. Res. Featuring Preclin. Clin. Cancer Ther. 2018, 26, 725\u2013734. 10.3727/096504017X15119467381615.", "ArticleIdList": ["10.3727/096504017X15119467381615", "PMC7844735", "29187267"]}, {"Citation": "Harrington K. J. The biology of cancer. Medicine 2016, 44, 1\u20135. 10.1016/j.mpmed.2015.10.005.", "ArticleIdList": ["10.1016/j.mpmed.2015.10.005"]}, {"Citation": "Mazumder S.; Plesca D.; Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Apoptosis Cancer 2008, 13\u201321. 10.1007/978-1-59745-339-4_2.", "ArticleIdList": ["10.1007/978-1-59745-339-4_2", "18175808"]}, {"Citation": "Woo M.; Hakem R.; Furlonger C.; et al. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat. Immunol. 2003, 4, 1016\u20131022. 10.1038/ni976.", "ArticleIdList": ["10.1038/ni976", "12970760"]}, {"Citation": "Earnshaw W. C.; Martins L. M.; Kaufmann S. H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999, 68, 383\u2013424. 10.1146/annurev.biochem.68.1.383.", "ArticleIdList": ["10.1146/annurev.biochem.68.1.383", "10872455"]}, {"Citation": "Naz H.; Tarique M.; Ahamad S.; et al. Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells. J. Cell. Biochem. 2019, 120, 15119\u201315130. 10.1002/jcb.28774.", "ArticleIdList": ["10.1002/jcb.28774", "31021496"]}, {"Citation": "Payne A. W.Role of ceramide kinase in breast cancer progression; Publicly Accessible Penn Dissertations, 2014."}, {"Citation": "Klec C.; Gutschner T.; Panzitt K.; Pichler M. Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention. Expert Opin. Ther. Targets 2019, 23, 177\u2013186. 10.1080/14728222.2019.1570499.", "ArticleIdList": ["10.1080/14728222.2019.1570499", "30678498"]}, {"Citation": "White C.; Alshaker H.; Cooper C.; Winkler M.; Pchejetski D. The emerging role of FTY720 (Fingolimod) in cancer treatment. Oncotarget 2016, 7, 23106.10.18632/oncotarget.7145.", "ArticleIdList": ["10.18632/oncotarget.7145", "PMC5029614", "27036015"]}, {"Citation": "Kunkel G. T.; Maceyka M.; Milstien S.; Spiegel S. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat. Rev. Drug Discovery 2013, 12, 688\u2013702. 10.1038/nrd4099.", "ArticleIdList": ["10.1038/nrd4099", "PMC3908769", "23954895"]}, {"Citation": "Watkins R.; Wu L.; Zhang C.; Davis R. M.; Xu B. Natural product-based nanomedicine: recent advances and issues. Int. J. Nanomed. 2015, 10, 6055.10.2147/IJN.S92162.", "ArticleIdList": ["10.2147/IJN.S92162", "PMC4592057", "26451111"]}, {"Citation": "Ramawat K, Dass S, Mathur M. The chemical diversity of bioactive molecules and therapeutic potential of medicinal plants. In Herbal drugs: ethnomedicine to modern medicine; Springer: 2009; 7\u201332, 10.1007/978-3-540-79116-4_2.", "ArticleIdList": ["10.1007/978-3-540-79116-4_2"]}, {"Citation": "Brizuela L.; Dayon A.; Doumerc N.; et al. The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. FASEB J. 2010, 24, 3882\u20133894. 10.1096/fj.10-160838.", "ArticleIdList": ["10.1096/fj.10-160838", "20522783"]}, {"Citation": "Kruczynski A.; Poli M.; Dossi R.; et al. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development. Eur. J. Cancer 2006, 42, 2821\u20132832. 10.1016/j.ejca.2006.06.019.", "ArticleIdList": ["10.1016/j.ejca.2006.06.019", "16973349"]}, {"Citation": "Sorensen J. B.; \u00d8sterlind K.; Hansen H. H. Vinca alkaloids in the treatment of non-small cell lung cancer. Cancer Treat. Rev. 1987, 14, 29\u201351. 10.1016/0305-7372(87)90049-1.", "ArticleIdList": ["10.1016/0305-7372(87)90049-1", "3036349"]}, {"Citation": "Beljanski M.; Beljanski M. Three alkaloids as selective destroyers of cancer cells in mice. Oncology 1986, 43, 198\u2013203. 10.1159/000226363.", "ArticleIdList": ["10.1159/000226363", "3703465"]}, {"Citation": "Shabani S. H. S.; Tehrani S. S. H.; Rabiei Z.; Enferadi S. T.; Vannozzi G. P. Peganum harmala L.\u2019s anti-growth effect on a breast cancer cell line. Biotechnol. Rep. 2015, 8, 138\u2013143. 10.1016/j.btre.2015.08.007.", "ArticleIdList": ["10.1016/j.btre.2015.08.007", "PMC4980734", "28352583"]}, {"Citation": "Zaidi N.; Ajmal M. R.; Rabbani G.; Ahmad E.; Khan R. H. A comprehensive insight into binding of hippuric acid to human serum albumin: a study to uncover its impaired elimination through hemodialysis. PLoS One 2013, 8, e7142210.1371/journal.pone.0071422.", "ArticleIdList": ["10.1371/journal.pone.0071422", "PMC3739763", "23951159"]}, {"Citation": "Rehman M. T.; Shamsi H.; Khan A. U. Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches. Mol. Pharmaceutics 2014, 11, 1785\u20131797. 10.1021/mp500116c.", "ArticleIdList": ["10.1021/mp500116c", "24745377"]}, {"Citation": "Keswani N.; Choudhary S.; Kishore N. Interaction of weakly bound antibiotics neomycin and lincomycin with bovine and human serum albumin: biophysical approach. J. Biochem. 2010, 148, 71\u201384. 10.1093/jb/mvq035.", "ArticleIdList": ["10.1093/jb/mvq035", "20356824"]}, {"Citation": "De Meester C. Genotoxic potential of \u03b2-carbolines: a review. Mutat. Res./Rev. Genet. Toxicol. 1995, 339, 139\u2013153. 10.1016/0165-1110(95)90008-X.", "ArticleIdList": ["10.1016/0165-1110(95)90008-X", "7491124"]}, {"Citation": "Mohamed A. H. S.; AL-Jammali S. M. J.; Naki Z. J. Effect of repeated administration of Peganum harmala alcoholic extract on the liver and kidney in Albino mice: a histo-pathological study. J. Sci. Innovative Res. 2013, 2, 585\u2013597."}, {"Citation": "Storch A.; Hwang Y. I.; Gearhart D. A.; et al. Dopamine transporter-mediated cytotoxicity of \u03b2-carbolinium derivatives related to Parkinson\u2019s disease: relationship to transporter-dependent uptake. J. Neurochem. 2004, 89, 685\u2013694. 10.1111/j.1471-4159.2004.02397.x.", "ArticleIdList": ["10.1111/j.1471-4159.2004.02397.x", "15086525"]}, {"Citation": "Bournine L.; Bensalem S.; Fatmi S.; et al. Evaluation of the cytotoxic and cytostatic activities of alkaloid extracts from different parts of Peganum harmala L.(Zygophyllaceae). Eur. J. Integr. Med. 2017, 9, 91\u201396. 10.1016/j.eujim.2016.10.002.", "ArticleIdList": ["10.1016/j.eujim.2016.10.002"]}, {"Citation": "Ghosh T.; Sarkar S.; Bhattacharjee P.; et al. In vitro relationship between serum protein binding to beta-carboline alkaloids: a comparative cytotoxic, spectroscopic and calorimetric assays. J. Biomol. Struct. Dyn. 2020, 38, 1103\u20131118. 10.1080/07391102.2019.1595727.", "ArticleIdList": ["10.1080/07391102.2019.1595727", "30909826"]}, {"Citation": "Gupta P.; Mohammad T.; Khan P.; et al. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy. Biomed. Pharmacother. 2019, 118, 109245.10.1016/j.biopha.2019.109245.", "ArticleIdList": ["10.1016/j.biopha.2019.109245", "31352240"]}, {"Citation": "Raghav D.; Ashraf S. M.; Mohan L.; Rathinasamy K. Berberine induces toxicity in HeLa cells through perturbation of microtubule polymerization by binding to tubulin at a unique site. Biochemistry 2017, 56, 2594\u20132611. 10.1021/acs.biochem.7b00101.", "ArticleIdList": ["10.1021/acs.biochem.7b00101", "28459539"]}, {"Citation": "Gupta K.; Panda D. Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity. Biochemistry 2002, 41, 13029\u201313038. 10.1021/bi025952r.", "ArticleIdList": ["10.1021/bi025952r", "12390030"]}, {"Citation": "Lakowicz J. R.. Principles of fluorescence spectroscopy; Springer Science & Business Media: 2013."}, {"Citation": "Wei X. L.; Xiao J. B.; Wang Y.; Bai Y. Which model based on fluorescence quenching is suitable to study the interaction between trans-resveratrol and BSA?. Spectrochim. Acta, Part A 2010, 75, 299\u2013304. 10.1016/j.saa.2009.10.027.", "ArticleIdList": ["10.1016/j.saa.2009.10.027", "19926336"]}, {"Citation": "Azevedo A. M. O.; Ribeiro D. M. G.; Pinto P. C. A. G.; L\u00facio M.; Reis S.; Saraiva M. L. M. F. S. Imidazolium ionic liquids as solvents of pharmaceuticals: influence on HSA binding and partition coefficient of nimesulide. Int. J. Pharm. 2013, 443, 273\u2013278. 10.1016/j.ijpharm.2012.12.030.", "ArticleIdList": ["10.1016/j.ijpharm.2012.12.030", "23287776"]}, {"Citation": "Copeland R. A.A practical introduction to structure, mechanism, and data analysis. Enzymes, 2nd ed. John Wiley & Sons, New York, NY: 2000: 104."}, {"Citation": "Voura M.; Khan P.; Thysiadis S.; et al. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones. Sci. Rep. 2019, 9, 1676.10.1038/s41598-018-38217-8.", "ArticleIdList": ["10.1038/s41598-018-38217-8", "PMC6368574", "30737440"]}, {"Citation": "Dahiya R.; Mohammad T.; Gupta P.; et al. Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3. RSC Adv. 2019, 9, 23302\u201323315. 10.1039/C9RA02864A.", "ArticleIdList": ["10.1039/C9RA02864A", "PMC9067284", "35514501"]}, {"Citation": "Morris G. M.; Huey R.; Lindstrom W.; et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785\u20132791. 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Trott O.; Olson A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010, 31, 455\u2013461. 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}]}], "History": [{"Year": "2020", "Month": "5", "Day": "9"}, {"Year": "2020", "Month": "8", "Day": "10"}, {"Year": "2020", "Month": "9", "Day": "9", "Hour": "18", "Minute": "12"}, {"Year": "2020", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["32905276", "PMC7469376", "10.1021/acsomega.0c02165"]}}]}